Surgical Management of Hereditary Colorectal Cancer Syndromes

  • Johannes Dörner
  • Mahmoud Taghavi Fallahpour
  • Gabriela Möslein


Due to the advances in molecular genetic diagnostics of adenomatous polyposis variants as well as nonpolyposis syndromes, identification of patients with a genetic predisposition and their at-risk relatives is becoming increasingly important in clinical practice. Knowledge of the specific risk profile is gaining significance and requires a clinically differentiated approach to correctly identify the indications for prophylactic and extended therapeutic surgery. In this chapter, decision-making and the technical details of the operation for different colorectal cancer (CRC) syndromes are outlined. Besides the more commonly known polyposis syndromes, such as familial adenomatous polyposis (FAP), surgeons should be able to clinically distinguish between attenuated and classical variants of FAP and be aware of MUTYH-associated polyposis (MAP) and the newly described polyposis polymerase proofreading-associated polyposis (PPAP), among others. Surgeons should be familiar with the specific indications and extent of surgery for prophylactic organ removal in the lower gastrointestinal tract to knowledgeably advise patients and enable them to make informed decisions. Moreover, reconstructive options after proctocolectomy and novel innovative techniques in proctectomy, such as the transanal total mesorectal excision (TaTME), are discussed.


Timing of surgery Ileal pouch-anal anastomosis Ileorectal anastomosis Quality of life Desmoid disease Prophylactic surgery 


  1. 1.
    Kobayashi H, Ishida H, Ueno H, et al. Association between the age and the development of colorectal cancer in patients with familial adenomatous polyposis: a multi-institutional study. Surg Today. 2017;47:690–6.CrossRefGoogle Scholar
  2. 2.
    Rajaratnam SG, Eglinton TW, Hider P, et al. Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Color Dis. 2011;26:1365.CrossRefGoogle Scholar
  3. 3.
    Warrier SK, Kalady MF. Familial adenomatous polyposis: challenges and pitfalls of surgical treatment. Clin Colon Rectal Surg. 2012;25:083–9.CrossRefGoogle Scholar
  4. 4.
    Gordon PH, Nivatvongs S. Principles and practice of surgery for the colon, rectum, and anus: CRC Press, Boca Raton, FL; 2007.Google Scholar
  5. 5.
    Debinski HS, Love S, Spigelman AD, et al. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology. 1996;110:1028–30.CrossRefGoogle Scholar
  6. 6.
    Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2:783–5.CrossRefGoogle Scholar
  7. 7.
    Lynch PM, Morris JS, Wen S, et al. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016;84:115–125.e114.CrossRefGoogle Scholar
  8. 8.
    Ishikawa H, Mutoh M, Iwama T, et al. Endoscopic management of familial adenomatous polyposis in patients refusing colectomy. Endoscopy. 2016;48:51–5.CrossRefGoogle Scholar
  9. 9.
    Nieuwenhuis MH, LM M–V, Slors FJ, et al. Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2007;5:374–8.CrossRefGoogle Scholar
  10. 10.
    Soravia C, Klein L, Berk T, et al. Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum. 1999;42:1028–33.CrossRefGoogle Scholar
  11. 11.
    Van Duijvendijk P, Slors J, Taat C, et al. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch—anal anastomosis for familial adenomatous polyposis. Br J Surg. 2000;87:590–6.CrossRefGoogle Scholar
  12. 12.
    Bülow C, Vasen H, Järvinen H, et al. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology. 2000;119:1454–60.CrossRefGoogle Scholar
  13. 13.
    Stelzner F. Homingareale bei erblichen, synchronen und metachronen Rektokolonkrebsen. Chirurg. 2006;77:1056–60.CrossRefGoogle Scholar
  14. 14.
    Koskenvuo L, Renkonen-Sinisalo L, Järvinen H, et al. Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis. Int J Color Dis. 2014;29:225–30.CrossRefGoogle Scholar
  15. 15.
    Bertario L, Russo A, Radice P, et al. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Ann Surg. 2000;231:538–43.CrossRefGoogle Scholar
  16. 16.
    Björk JA, Åkerbrant HI, Iselius LE, et al. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Dis Colon Rectum. 2000;43:1719–25.CrossRefGoogle Scholar
  17. 17.
    Bülow S, Bülow C, Vasen H, et al. Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum. 2008;51:1318.CrossRefGoogle Scholar
  18. 18.
    Durno C, Monga N, Bapat B, et al. Does early colectomy increase Desmoid risk in familial adenomatous polyposis? Clin Gastroenterol Hepatol. 2007;5:1190–4.CrossRefGoogle Scholar
  19. 19.
    Sturt NJH, Clark SK. Current ideas in desmoid tumours. Familial Cancer. 2006;5:275–85.CrossRefGoogle Scholar
  20. 20.
    Church JM, Xhaja X, Warrier SK, et al. Desmoid tumors do not prevent proctectomy following abdominal colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum. 2014;57:343–7.CrossRefGoogle Scholar
  21. 21.
    Larson DW, Davies MM, Dozois EJ, et al. Sexual function, body image, and quality of life after laparoscopic and open ileal pouch-anal anastomosis. Dis Colon Rectum. 2008;51:392–6.CrossRefGoogle Scholar
  22. 22.
    Kock NG. Intra-abdominal “reservoir” in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal “continence” in five ileostomy patients. Arch Surg (Chicago, Ill 1960). 1969;99:223–31.CrossRefGoogle Scholar
  23. 23.
    Gerber A, Apt MK, Craig PH. The improved quality of life with the Kock continent ileostomy. J Clin Gastroenterol. 1984;6:513–7.CrossRefGoogle Scholar
  24. 24.
    Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372:1324–32.CrossRefGoogle Scholar
  25. 25.
    Indar AA, Efron JE, Young-Fadok TM. Laparoscopic ileal pouch–anal anastomosis reduces abdominal and pelvic adhesions. Surg Endosc. 2009;23:174.CrossRefGoogle Scholar
  26. 26.
    Bartels SA, D'hoore A, Cuesta MA, et al. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256:1045–8.CrossRefGoogle Scholar
  27. 27.
    Fajardo AD, Dharmarajan S, George V, et al. Laparoscopic versus open 2-stage ileal pouch: laparoscopic approach allows for faster restoration of intestinal continuity. J Am Coll Surg. 2010;211:377–83.CrossRefGoogle Scholar
  28. 28.
    Schiessling S, Leowardi C, Kienle P, et al. Laparoscopic versus conventional ileoanal pouch procedure in patients undergoing elective restorative proctocolectomy (LapConPouch Trial)—a randomized controlled trial. Langenbeck's Arch Surg. 2013;398:807–16.CrossRefGoogle Scholar
  29. 29.
    Maartense S, Dunker MS, Slors JF, et al. Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch anal anastomosis: a randomized trial. Ann Surg. 2004;240:984–92.CrossRefGoogle Scholar
  30. 30.
    Ueno H, Kobayashi H, Konishi T, et al. Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol. 2016;21:713–22.CrossRefGoogle Scholar
  31. 31.
    Lindsey I, Guy R, Warren B, et al. Anatomy of Denonvilliers’ fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg. 2000;87:1288–99.CrossRefGoogle Scholar
  32. 32.
    De Zeeuw S, Ahmed Ali U, Van Der Kolk MB, et al. Ileal pouch anal anastomosis with close rectal dissection using automated vessel sealers for ulcerative colitis: a promising alternative. Dig Surg. 2011;28:345–51.CrossRefGoogle Scholar
  33. 33.
    Lindsey I, George BD, Kettlewell MGW, et al. Impotence after mesorectal and close rectal dissection for inflammatory bowel disease. Dis Colon Rectum. 2001;44:831–5.CrossRefGoogle Scholar
  34. 34.
    Bartels S, Gardenbroek T, Aarts M, et al. Short-term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch–anal anastomosis. Br J Surg. 2015;102:281–7.CrossRefGoogle Scholar
  35. 35.
    Sylla P, Rattner DW, Delgado S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24:1205–10.CrossRefGoogle Scholar
  36. 36.
    Leo CA, Samaranayake S, Perry-Woodford ZL, et al. Initial experience of restorative proctocolectomy for ulcerative colitis by transanal total mesorectal rectal excision and single-incision abdominal laparoscopic surgery. Color Dis. 2016;18:1162–6.CrossRefGoogle Scholar
  37. 37.
    Koedam T, Van Ramshorst G, Deijen C, et al. Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol. 2017;21:25–33.CrossRefGoogle Scholar
  38. 38.
    Kirat HT, Remzi FH. Technical aspects of ileoanal pouch surgery in patients with ulcerative colitis. Clin Colon Rectal Surg. 2010;23:239–47.CrossRefGoogle Scholar
  39. 39.
    Möslein G. Surgical considerations in FAP-related pouch surgery: could we do better? Fam Cancer. 2016;15:457–66.CrossRefGoogle Scholar
  40. 40.
    Parks A, Nicholls R. Proctocolectomy without ileostomy for ulcerative colitis. Br Med J. 1978;2:85–8.CrossRefGoogle Scholar
  41. 41.
    Heald R, Allen D. Stapled ileo-anal anastomosis: a technique to avoid mucosal proctectomy in the ileal pouch operation. Br J Surg. 1986;73:571–2.CrossRefGoogle Scholar
  42. 42.
    Slors J, Ponson A, Taat C, et al. Risk of residual rectal mucosa after proctocolectomy and ileal pouch-anal reconstruction with the double-stapling technique. Dis Colon Rectum. 1995;38:207–10.CrossRefGoogle Scholar
  43. 43.
    Von Roon AC, Will OC, Man RF, et al. Mucosectomy with handsewn anastomosis reduces the risk of adenoma formation in the anorectal segment after restorative proctocolectomy for familial adenomatous polyposis. Ann Surg. 2011;253:314–7.CrossRefGoogle Scholar
  44. 44.
    Ganschow P, Treiber I, Hinz U, et al. Residual rectal mucosa after stapled vs. handsewn ileal J-pouch-anal anastomosis in patients with familial adenomatous polyposis coli (FAP)—a critical issue. Langenbeck's Arch Surg. 2015;400:213–9.CrossRefGoogle Scholar
  45. 45.
    Silva-Velazco J, Stocchi L, Wu X-R, et al. Twenty-year-old stapled pouches for ulcerative colitis without evidence of rectal cancer: implications for surveillance strategy? Dis Colon Rectum. 2014;57:1275–81.CrossRefGoogle Scholar
  46. 46.
    Utsunomiya J, Iwama T, Imajo M, et al. Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum. 1980;23:459–66.CrossRefGoogle Scholar
  47. 47.
    Hughes JP, Bauer AR, Bauer CM. Stapling techniques for easy construction of an ileal J-pouch. Am J Surg. 1988;155:783–5.CrossRefGoogle Scholar
  48. 48.
    Schneider R, Schneider C, Dalchow A, et al. Prophylactic surgery in familial adenomatous polyposis (FAP)—a single surgeon’s short-and long-term experience with hand-assisted proctocolectomy and smaller J-pouches. Int J Color Dis. 2015;30:1109–15.CrossRefGoogle Scholar
  49. 49.
    Block M, Börjesson L, Lindholm E, et al. Pouch design and long-term functional outcome after ileal pouch–anal anastomosis. Br J Surg. 2009;96:527–32.CrossRefGoogle Scholar
  50. 50.
    Campos FG. Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World Journal of Gastroenterology : WJG. 2014;20:16620–9.CrossRefGoogle Scholar
  51. 51.
    Carne PWG, Pemberton JH. Technical aspects of ileoanal pouch surgery. Clin Colon Rectal Surg. 2004;17:35–41.CrossRefGoogle Scholar
  52. 52.
    Sagar PM, Lewis W, Holdsworth PJ, et al. One-stage restorative proctocolectomy without temporary defunctioning ileostomy. Dis Colon Rectum. 1992;35:582–8.CrossRefGoogle Scholar
  53. 53.
    Heuschen UA, Hinz U, Allemeyer EH, et al. Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg. 2002;235:207–16.CrossRefGoogle Scholar
  54. 54.
    Miccini M, Bonapasta SA, Gregori M, et al. Ghost ileostomy: real and potential advantages. Am J Surg. 2010;200:e55–7.CrossRefGoogle Scholar
  55. 55.
    Mari FS, Di Cesare T, Novi L, et al. Does ghost ileostomy have a role in the laparoscopic rectal surgery era? A randomized controlled trial. Surg Endosc. 2015;29:2590–7.CrossRefGoogle Scholar
  56. 56.
    Hartley J, Church J, Gupta S, et al. Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum. 2004;47:334–40.CrossRefGoogle Scholar
  57. 57.
    Quast DR, Schneider R, Burdzik E, et al. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Familial Cancer. 2016;15:31–40.CrossRefGoogle Scholar
  58. 58.
    Brosens LA, Keller JJ, Offerhaus GJA, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut. 2005;54:1034–43.CrossRefGoogle Scholar
  59. 59.
    Galle TS, Juel K, Bülow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol. 1999;34:808–12.CrossRefGoogle Scholar
  60. 60.
    Groves C, Saunders B, Spigelman A, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut. 2002;50:636–41.CrossRefGoogle Scholar
  61. 61.
    Kalady MF, Clary BM, Tyler DS, et al. Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg. 2002;6:82–7.CrossRefGoogle Scholar
  62. 62.
    Watanabe Y, Ishida H, Baba H, et al. Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution. Fam Cancer. 2017;16:91–8.CrossRefGoogle Scholar
  63. 63.
    Samadder NJ, Neklason DW, Boucher KM, et al. Effect of sulindac and erlotinib vs placebo on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial. JAMA. 2016;315:1266–75.CrossRefGoogle Scholar
  64. 64.
    Møller P, Seppälä T, Bernstein I et al. Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective lynch syndrome database. Gut. 2016.Google Scholar
  65. 65.
    (Nice) TNIOCE. Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27): NICE guidance; 2017.Google Scholar
  66. 66.
    Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;66:1657–64.Google Scholar
  67. 67.
    Kastrinos F, Syngal S. Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol. 2012;30:1024–7.CrossRefGoogle Scholar
  68. 68.
    Pearlman R, Frankel WL, Swanson B et al. Prevalence and Spectrum of Germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2016.Google Scholar
  69. 69.
    Yurgelun MB, Kulke MH, Fuchs CS et al. (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 0:JCO.2016.2071.0012.Google Scholar
  70. 70.
    Kumarasinghe AP, De Boer B, Bateman AC, et al. DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material. Pathology. 2010;42:414–20.CrossRefGoogle Scholar
  71. 71.
    Vilkin A, Leibovici-Weissman YA, Halpern M, et al. Immunohistochemistry staining for mismatch repair proteins: the endoscopic biopsy material provides useful and coherent results. Hum Pathol. 2015;46:1705–11.CrossRefGoogle Scholar
  72. 72.
    Kim TJ, Kim ER, Hong SN, et al. Survival outcome and risk of metachronous colorectal cancer after surgery in Lynch syndrome. Ann Surg Oncol. 2017;66:1657–64.Google Scholar
  73. 73.
    Fitzgibbons R Jr, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg. 1987;206:289.CrossRefGoogle Scholar
  74. 74.
    Stupart DA, Goldberg PA, Baigrie RJ, et al. Surgery for colonic cancer in HNPCC: total vs segmental colectomy. Color Dis. 2011;13:1395–9.CrossRefGoogle Scholar
  75. 75.
    Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2010;2010:228056.Google Scholar
  76. 76.
    De Vos Tot Nederveen Cappel WH, Buskens E, Van Duijvendijk P, et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut. 2003;52:1752–5.CrossRefGoogle Scholar
  77. 77.
    Syngal S, Weeks JC, Schrag D, et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998;129:787–96.CrossRefGoogle Scholar
  78. 78.
    Maeda T, Cannom RR, Beart RW Jr, et al. Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2010;28:1175–80.CrossRefGoogle Scholar
  79. 79.
    Elton C, Makin G, Hitos K, et al. Mortality, morbidity and functional outcome after ileorectal anastomosis. Br J Surg. 2003;90:59–65.CrossRefGoogle Scholar
  80. 80.
    Haanstra JF, Tot Nederveen WHDV, Gopie JP, et al. Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum. 2012;55:653–9.CrossRefGoogle Scholar
  81. 81.
    Cirillo L, Urso ED, Parrinello G, et al. High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling the Amsterdam criteria. Ann Surg. 2013;257:900–4.CrossRefGoogle Scholar
  82. 82.
    Kalady MF, Mcgannon E, Vogel JD, et al. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg. 2010;252:507–13.PubMedGoogle Scholar
  83. 83.
    Rodríguez-Bigas MA, Vasen H, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997;225:202.CrossRefGoogle Scholar
  84. 84.
    Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711–8.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Lee JS, Petrelli NJ, Rodriguez-Bigas MA. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg. 2001;181:207–10.CrossRefGoogle Scholar
  86. 86.
    Kalady MF, Lipman J, Mcgannon E, et al. Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg. 2012;255:1121–5.CrossRefGoogle Scholar
  87. 87.
    Meagher A, Farouk R, Dozois R, et al. J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800–3.CrossRefGoogle Scholar
  88. 88.
    HFA V, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62:812–23.CrossRefGoogle Scholar
  89. 89.
    Burn J, Gerdes A-M, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2012;378:2081–7.CrossRefGoogle Scholar
  90. 90.
    Burn J, Sheth H. The role of aspirin in preventing colorectal cancer. Br Med Bull. 2016;119:17–24.CrossRefGoogle Scholar
  91. 91.
    Jass J, Smyrk TC, Stewart S, et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res. 1993;14:1631–4.Google Scholar
  92. 92.
    Vasen HF, Abdirahman M, Brohet R, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology. 2010;138:2300–6.CrossRefGoogle Scholar
  93. 93.
    Møller P, Seppälä T, Bernstein I, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut:gutjnl-2015-309675; 2015.Google Scholar
  94. 94.
    Aarnio M, Mecklin JP, Aaltonen LA, et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (hnpcc) syndrome. Int J Cancer. 1995;64:430–3.CrossRefGoogle Scholar
  95. 95.
    Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–10.CrossRefGoogle Scholar
  96. 96.
    Quehenberger F, Vasen H, Van Houwelingen H. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42:491–6.CrossRefGoogle Scholar
  97. 97.
    Obermair A, Youlden DR, Young JP, et al. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010;127:2678–84.CrossRefGoogle Scholar
  98. 98.
    Faubion S, Kuhle CL, Shuster LT, et al. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18:483–91.CrossRefGoogle Scholar
  99. 99.
    Schmeler KM, Lynch HT, Chen L-M, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006;354:261–9.CrossRefGoogle Scholar
  100. 100.
    Boks DE, Trujillo AP, Voogd AC, et al. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer. 2002;102:198–200.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Johannes Dörner
    • 1
  • Mahmoud Taghavi Fallahpour
    • 2
  • Gabriela Möslein
    • 3
  1. 1.Klinik für Allgemein- und Viszeralchirurgie, HELIOS University Hospital Witten/HerdeckeWuppertalGermany
  2. 2.Private University Witten/HerdeckeWittenGermany
  3. 3.Center for Hereditary Tumours, HELIOS University Hospital Witten/HerdeckeWuppertalGermany

Personalised recommendations